Skip to main content

Multiple Myeloma

Multiple Myeloma, Oncology
Four-Drug Induction and 2-Drug Maintenance Boost Overall Survival in Patients with Newly Diagnosed Myeloma
Audrey Andrews
Read More
Multiple Myeloma, Oncology
Host Factors Important in Patients with Myeloma
Caroline Helwick
Read More
Multiple Myeloma, Oncology
New Data Demonstrate Overall Survival Benefit with Pomalidomide in Advanced Myeloma
Caroline Helwick
Read More
Multiple Myeloma, Oncology
Pomalidomide Shows Strong Activity in Relapsed/Refractory Myeloma
Caroline Helwick
Read More
Multiple Myeloma, Oncology
First Oral Proteasome Inhibitor Active in Myeloma
Read More
Multiple Myeloma, Multiple Myeloma, Oncology
VISTA Final Analysis Upholds Survival Benefit of Bortezomib at 5 Years
Caroline Helwick, Caroline Helwick
Read More
Multiple Myeloma, Multiple Myeloma, Oncology
Maintenance Strategies in Elderly Patients with Myeloma Not Eligible for Transplant
Caroline Helwick, Caroline Helwick
Read More
Multiple Myeloma, Multiple Myeloma, Oncology
Monoclonal Antibody Elotuzumab Promising in Multiple Myeloma
Read More
Multiple Myeloma, Multiple Myeloma, Multiple Myeloma, Oncology
Pomalidomide a Promising New Immunomodulatory Drug for Multiple Myeloma
Read More
Multiple Myeloma, Multiple Myeloma, Oncology
Next-Generation Proteasome Inhibitors Cause Less Peripheral Neuropathy
Caroline Helwick, Caroline Helwick
Read More
Page 5 of 6
Results 41 - 50 of 53